Company Overview of Prevtec Microbia Inc.
Prevtec Microbia Inc., a biotechnology company, develops, manufactures, and markets technologies and products for the prevention of bacterial infections and the improvement of performance in food animal production. It offers Coliprotec, a live vaccine to prevent post-weaning diarrhea (PWD) in pigs caused by F4 (K88)-positive E. coli bacteria. Prevtec Microbia Inc. was founded in 2003 and is based in Montreal, Canada it has operations in Canada and Europe.
1250 Rene-Levesque Boulevard West
Montreal, QC H3B 4W8
Founded in 2003
Key Executives for Prevtec Microbia Inc.
Prevtec Microbia Inc. Key Developments
Similar Private Companies By Industry
|2007262 Ontario, Inc.||Americas|
|2056273 Ontario, Inc.||Americas|
|AB BioPharma Inc.||Americas|
|AbCelex Technologies Inc.||Americas|
|AbCellera Biologics Inc.||Americas|
Recent Private Companies Transactions
March 21, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Prevtec Microbia Inc., please visit www.prevtecmicrobia.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.